GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roquefort Therapeutics PLC (LSE:ROQ) » Definitions » Net Interest Income (for Banks)

Roquefort Therapeutics (LSE:ROQ) Net Interest Income (for Banks)


View and export this data going back to 2021. Start your Free Trial

What is Roquefort Therapeutics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Roquefort Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
85 Great Portland Street, First Floor, London, GBR, W1W 7LT
Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses. Its product portfolio consists of MDK Antibody, MDK Oligo, MDK mRNA, STAT-6 siRNA, and MK Cell. The principal activity of the Company is to develop pre-clinical next-generation medicines focused on hard-to-treat cancers.